182 related articles for article (PubMed ID: 37291760)
1. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Schultz SA; Shirzadi Z; Schultz AP; Liu L; Fitzpatrick CD; McDade E; Barthelemy NR; Renton A; Esposito B; Joseph-Mathurin N; Cruchaga C; Chen CD; Goate A; Allegri RF; Benzinger TLS; Berman S; Chui HC; Fagan AM; Farlow MR; Fox NC; Gordon BA; Day GS; Graff-Radford NR; Hassenstab JJ; Hanseeuw BJ; Hofmann A; Jack CR; Jucker M; Karch CM; Koeppe RA; Lee JH; Levey AI; Levin J; Martins RN; Mori H; Morris JC; Noble J; Perrin RJ; Rosa-Neto P; Salloway SP; Sanchez-Valle R; Schofield PR; Xiong C; Johnson KA; Bateman RJ; Sperling RA; Chhatwal JP;
Aging Cell; 2023 Aug; 22(8):e13871. PubMed ID: 37291760
[TBL] [Abstract][Full Text] [Related]
2. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.
Chhatwal JP; Schultz SA; McDade E; Schultz AP; Liu L; Hanseeuw BJ; Joseph-Mathurin N; Feldman R; Fitzpatrick CD; Sparks KP; Levin J; Berman SB; Renton AE; Esposito BT; Fernandez MV; Sung YJ; Lee JH; Klunk WE; Hofmann A; Noble JM; Graff-Radford N; Mori H; Salloway SM; Masters CL; Martins R; Karch CM; Xiong C; Cruchaga C; Perrin RJ; Gordon BA; Benzinger TLS; Fox NC; Schofield PR; Fagan AM; Goate AM; Morris JC; Bateman RJ; Johnson KA; Sperling RA;
Lancet Neurol; 2022 Feb; 21(2):140-152. PubMed ID: 35065037
[TBL] [Abstract][Full Text] [Related]
3. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
[TBL] [Abstract][Full Text] [Related]
4. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
[TBL] [Abstract][Full Text] [Related]
5. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
[TBL] [Abstract][Full Text] [Related]
6. The
Almkvist O; Graff C
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946903
[TBL] [Abstract][Full Text] [Related]
7. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
8. Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease.
Moore B; Sharma A; Goulet M; Suter T; Pelletier C; Hu R; Schaeffer E; Kelleher RJ
Hum Gene Ther; 2023 Oct; 34(19-20):1049-1063. PubMed ID: 37578141
[TBL] [Abstract][Full Text] [Related]
9. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
[TBL] [Abstract][Full Text] [Related]
10. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
Quiroz YT; Schultz AP; Chen K; Protas HD; Brickhouse M; Fleisher AS; Langbaum JB; Thiyyagura P; Fagan AM; Shah AR; Muniz M; Arboleda-Velasquez JF; Munoz C; Garcia G; Acosta-Baena N; Giraldo M; Tirado V; Ramírez DL; Tariot PN; Dickerson BC; Sperling RA; Lopera F; Reiman EM
JAMA Neurol; 2015 Aug; 72(8):912-9. PubMed ID: 26121081
[TBL] [Abstract][Full Text] [Related]
11. PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers.
Ghisays V; Lopera F; Goradia DD; Protas HD; Malek-Ahmadi MH; Chen Y; Devadas V; Luo J; Lee W; Baena A; Bocanegra Y; Guzmán-Vélez E; Pardilla-Delgado E; Vila-Castelar C; Fox-Fuller JT; Hu N; Clayton D; Thomas RG; Alvarez S; Espinosa A; Acosta-Baena N; Giraldo MM; Rios-Romenets S; Langbaum JB; Chen K; Su Y; Tariot PN; Quiroz YT; Reiman EM;
Neuroimage Clin; 2021; 31():102749. PubMed ID: 34252876
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
[TBL] [Abstract][Full Text] [Related]
14. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
Boerwinkle AH; Gordon BA; Wisch J; Flores S; Henson RL; Butt OH; McKay N; Chen CD; Benzinger TLS; Fagan AM; Handen BL; Christian BT; Head E; Mapstone M; Rafii MS; O'Bryant S; Lai F; Rosas HD; Lee JH; Silverman W; Brickman AM; Chhatwal JP; Cruchaga C; Perrin RJ; Xiong C; Hassenstab J; McDade E; Bateman RJ; Ances BM; ;
Lancet Neurol; 2023 Jan; 22(1):55-65. PubMed ID: 36517172
[TBL] [Abstract][Full Text] [Related]
15. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.
Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gutierrez Gomez M; Langois CM; Langbaum JB; Roontiva A; Thiyyagura P; Lee W; Ayutyanont N; Lopez L; Moreno S; Muñoz C; Tirado V; Acosta-Baena N; Fagan AM; Giraldo M; Garcia G; Huentelman MJ; Tariot PN; Lopera F; Reiman EM
JAMA Neurol; 2015 Mar; 72(3):316-24. PubMed ID: 25580592
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study.
Sanchez JS; Hanseeuw BJ; Lopera F; Sperling RA; Baena A; Bocanegra Y; Aguillon D; Guzmán-Vélez E; Pardilla-Delgado E; Ramirez-Gomez L; Vila-Castelar C; Martinez JE; Fox-Fuller JT; Ramos C; Ochoa-Escudero M; Alvarez S; Jacobs HIL; Schultz AP; Gatchel JR; Becker JA; Katz SR; Mayblyum DV; Price JC; Reiman EM; Johnson KA; Quiroz YT
Alzheimers Res Ther; 2021 Jan; 13(1):27. PubMed ID: 33451357
[TBL] [Abstract][Full Text] [Related]
17. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
[TBL] [Abstract][Full Text] [Related]
18. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
[TBL] [Abstract][Full Text] [Related]
19. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease.
Millar PR; Gordon BA; Wisch JK; Schultz SA; Benzinger TL; Cruchaga C; Hassenstab JJ; Ibanez L; Karch C; Llibre-Guerra JJ; Morris JC; Perrin RJ; Supnet-Bell C; Xiong C; Allegri RF; Berman SB; Chhatwal JP; Chrem Mendez PA; Day GS; Hofmann A; Ikeuchi T; Jucker M; Lee JH; Levin J; Lopera F; Niimi Y; Sánchez-González VJ; Schofield PR; Sosa-Ortiz AL; Vöglein J; ; Bateman RJ; Ances BM; McDade EM
Mol Neurodegener; 2023 Dec; 18(1):98. PubMed ID: 38111006
[TBL] [Abstract][Full Text] [Related]
20. APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease.
Almkvist O; Johansson C; Laffita-Mesa J; Thordardottir S; Graff C
Eur J Neurol; 2022 Dec; 29(12):3580-3589. PubMed ID: 36039401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
